Millennium Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.5M | Sell |
62,730
-317,038
| -83% | -$243M | 0.02% | 848 |
|
|
2025
Q4 | $293M | Buy |
379,768
+178,688
| +89% | +$121M | 0.12% | 116 |
|
|
2025
Q3 | $113M | Sell |
201,080
-137,746
| -41% | -$77.9M | 0.05% | 383 |
|
|
2025
Q2 | $178M | Buy |
338,826
+169,241
| +100% | +$94.5M | 0.09% | 193 |
|
|
2025
Q1 | $108M | Buy |
169,585
+36,078
| +27% | +$24.8M | 0.06% | 321 |
|
|
2024
Q4 | $95.1M | Sell |
133,507
-67,667
| -34% | -$56.8M | 0.05% | 421 |
|
|
2024
Q3 | $211M | Sell |
201,174
-65,858
| -25% | -$73.3M | 0.1% | 159 |
|
|
2024
Q2 | $281M | Buy |
267,032
+67,826
| +34% | +$65.8M | 0.13% | 117 |
|
|
2024
Q1 | $192M | Sell |
199,206
-81,075
| -29% | -$77.1M | 0.08% | 218 |
|
|
2023
Q4 | $246M | Buy |
280,281
+243,272
| +657% | +$200M | 0.11% | 136 |
|
|
2023
Q3 | $30.5M | Sell |
37,009
-12,650
| -25% | -$9.94M | 0.02% | 1077 |
|
|
2023
Q2 | $35.7M | Sell |
49,659
-226,914
| -82% | -$175M | 0.02% | 964 |
|
|
2023
Q1 | $227M | Buy |
276,573
+242,590
| +714% | +$183M | 0.13% | 98 |
|
|
2022
Q4 | $24.5M | Buy |
33,983
+22,876
| +206% | +$16.9M | 0.01% | 1269 |
|
|
2022
Q3 | $7.65M | Buy |
11,107
+4,906
| +79% | +$3.09M | ﹤0.01% | 2476 |
|
|
2022
Q2 | $3.67M | Sell |
6,201
-22,484
| -78% | -$14.6M | ﹤0.01% | 3108 |
|
|
2022
Q1 | $20M | Sell |
28,685
-96,109
| -77% | -$60.8M | 0.01% | 1395 |
|
|
2021
Q4 | $78.8M | Buy |
124,794
+55,338
| +80% | +$34M | 0.04% | 466 |
|
|
2021
Q3 | $42M | Sell |
69,456
-115,035
| -62% | -$71.4M | 0.03% | 739 |
|
|
2021
Q2 | $103M | Sell |
184,491
-5,091
| -3% | -$2.58M | 0.06% | 285 |
|
|
2021
Q1 | $89.7M | Buy |
189,582
+4,803
| +3% | +$2.34M | 0.06% | 260 |
|
|
2020
Q4 | $89.3M | Buy |
184,779
+171,745
| +1,318% | +$92.7M | 0.06% | 246 |
|
|
2020
Q3 | $7.3K | Buy |
13,034
+7,588
| +139% | +$4.6M | 0.01% | 1518 |
|
|
2020
Q2 | $3.4M | Sell |
5,446
-87,934
| -94% | -$49.9M | ﹤0.01% | 2112 |
|
|
2020
Q1 | $45.6M | Sell |
93,380
-5,426
| -5% | -$2.24M | 0.1% | 174 |
|
|
2019
Q4 | $37.1M | Sell |
98,806
-246,382
| -71% | -$82.9M | 0.05% | 503 |
|
|
2019
Q3 | $95.8M | Sell |
345,188
-128,130
| -27% | -$37.9M | 0.15% | 120 |
|
|
2019
Q2 | $148M | Buy |
473,318
+439,550
| +1,302% | +$146M | 0.22% | 63 |
|
|
2019
Q1 | $13.9M | Buy |
33,768
+16,033
| +90% | +$6.6M | 0.02% | 1039 |
|
|
2018
Q4 | $6.62M | Sell |
17,735
-87,854
| -83% | -$32.2M | 0.01% | 1388 |
|
|
2018
Q3 | $42.7M | Buy |
105,589
+32,674
| +45% | +$12.4M | 0.05% | 479 |
|
|
2018
Q2 | $25.2M | Sell |
72,915
-129,431
| -64% | -$40.5M | 0.03% | 741 |
|
|
2018
Q1 | $69.7M | Sell |
202,346
-275,898
| -58% | -$96M | 0.09% | 297 |
|
|
2017
Q4 | $180M | Buy |
478,244
+276,154
| +137% | +$112M | 0.25% | 45 |
|
|
2017
Q3 | $90.4M | Buy |
202,090
+189,365
| +1,488% | +$90.1M | 0.14% | 151 |
|
|
2017
Q2 | $6.25M | Buy |
+12,725
| New | +$5.57M | 0.01% | 1356 |
|
|
2017
Q1 | – | Sell |
-85,875
| Closed | -$31.8M | – | 3793 |
|
|
2016
Q4 | $31.5M | Buy |
85,875
+77,010
| +869% | +$29.3M | 0.07% | 425 |
|
|
2016
Q3 | $3.56M | Sell |
8,865
-59,606
| -87% | -$23.9M | 0.01% | 1568 |
|
|
2016
Q2 | $23.9M | Sell |
68,471
-59,147
| -46% | -$22.8M | 0.05% | 448 |
|
|
2016
Q1 | $46M | Buy |
127,618
+3,759
| +3% | +$1.55M | 0.12% | 203 |
|
|
2015
Q4 | $67.2M | Buy |
123,859
+42,458
| +52% | +$23M | 0.14% | 140 |
|
|
2015
Q3 | $37.9M | Buy |
81,401
+78,079
| +2,350% | +$41.9M | 0.07% | 329 |
|
|
2015
Q2 | $1.7M | Sell |
3,322
-74,195
| -96% | -$36.2M | ﹤0.01% | 2015 |
|
|
2015
Q1 | $35M | Sell |
77,517
-63,404
| -45% | -$26.9M | 0.07% | 394 |
|
|
2014
Q4 | $57.8M | Buy |
140,921
+134,957
| +2,263% | +$53.1M | 0.12% | 184 |
|
|
2014
Q3 | $2.15M | Sell |
5,964
-83,028
| -93% | -$27.8M | 0.01% | 1819 |
|
|
2014
Q2 | $25.1M | Sell |
88,992
-172
| -0.2% | -$51K | 0.07% | 372 |
|
|
2014
Q1 | $26.8M | Sell |
89,164
-53,466
| -37% | -$16.5M | 0.08% | 335 |
|
|
2013
Q4 | $39.3M | Buy |
142,630
+120,458
| +543% | +$34.6M | 0.12% | 151 |
|
|
2013
Q3 | $6.94M | Sell |
22,172
-111,981
| -83% | -$29.5M | 0.02% | 923 |
|
|
2013
Q2 | $30.2M | Buy |
+134,153
| New | +$31.2M | 0.09% | 173 |
|
Other funds holding REGN
VCM
N
Millennium Management's REGN Position: Q1 2026 in Review
Millennium Management reduced its Regeneron Pharmaceuticals (REGN) stake by 83% in Q1 2026, selling an estimated $243M and leaving 62,730 shares worth $48.5M. The position accounts for 0.02% of the portfolio, ranked #848.
Millennium Management first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $293M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Millennium Management held 62,730 shares of Regeneron Pharmaceuticals worth $48.5M as of Q1 2026.
- Millennium Management sold 317,038 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $243M.
- Regeneron Pharmaceuticals made up 0.02% of Millennium Management's portfolio in Q1 2026, its #848 holding.
- Millennium Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Regeneron Pharmaceuticals position peaked at $293M in Q4 2025.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.